World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 13 January 2015
Main ID:  ISRCTN74040048
Date of registration: 28/09/2007
Prospective Registration: No
Primary sponsor: Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Public title: Pilot study of Homeopathic Treatment of Fibromyalgia Syndrome
Scientific title:
Date of first enrolment: 01/01/2006
Target sample size: 60
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN74040048
Study type:  Interventional
Study design:  Prospective pragmatic parallel group single blind randomised controlled pilot study (Treatment)  
Phase: 
Countries of recruitment
United Kingdom
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Ade    Adebajo
Address:  Dept of Rheumatology Barnsley District General Hospital Gawber Road S75 2EP Barnsley United Kingdom
Telephone: +44 01226 777867
Email: a.o.adebajo@sheffield.ac.uk
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Primary Fibromyalgia diagnoses (According to American College of Rheumatologists criteria for FMS)
2. Aged 18 years old and over
3. Score of 4 or more on FIQ pain scale (score 0-10 with 10 indicating very severe pain) at initial recruitment/assessment interview

Exclusion criteria: 1. Pain from traumatic injury or structural disease
2. Secondary Fibromyalgia
3. Rheumatoid Arthritis
4. Inflammatory Arthritis
5. Autoimmune Disease
6. Immunosuppressant Drugs
7. Current oral steroid treatment
8. Substance abuse in last year
9. Primary psychiatric diagnosis or medication prior to onset of Fibromyalgia
10. Unstable medical or psychiatric illness
11. Chronic use of sedatives
12. Pregnant or breast feeding
13. Current acupuncture treatment
14. Homeopathic treatment in the previous three months
15. Patients not fluent in English


Age minimum:
Age maximum:
Gender: Not Specified
Health Condition(s) or Problem(s) studied
Musculoskeletal Diseases: Fibromyalgia
Musculoskeletal Diseases
Fibromyalgia
Intervention(s)
Homeopathy referral + usual care vs usual care.
Primary Outcome(s)
Difference between the Fibromyalgia Impact Questionnaire (FIQ) total score (0-80 with 0 indicating no impact), at week 22, between the experimental and control groups.
Secondary Outcome(s)
1.Short form McGill Pain Questionnaire
2. Measure Your Medical Outcomes Profile (MYMOP)
3. FIQ Pain score
4. FIQ fatigue score
5. FIQ tiredness on awakening score
6. FIQ stiffness score
7. EQ-5D Quality of life score
8. Hospital anxiety and depression scale (HAD)
9. Tender point count (Performed by blinded assessor)
10. Medication Change Questionnaire
Secondary ID(s)
N0034178702
Source(s) of Monetary Support
Barnsley Hospital NHS Foundation Trust, BDGH Small Projects Fund
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history